Infection Prevention and Control Market Impacted By Increase In HIAS


A subtle increase has been observed in hospital-acquired infections (HIAS) in many countries of the world. Being a storehouse for different kinds of pathogens, bacteria, and viruses, hospitals and clinics are often responsible for the incessant spreading of certain communicable diseases. The Centre for Disease Control and Prevention has assessed that around 2 million patients every year experience the ill-effects of infections acquired by contaminated hospital environments annually according to business intelligence report published by IndustryARC. According to the report, the infection prevention and control market will expand with a CAGR of 5.3% during the forecast period 2018-2023.

The IndustryARC report is titled ‘Infection prevention & Control Market: By Infections (Microbial & Others); By Antimicrobial Drugs (Antibacterial & Others); By Accessories & Equipment (Disinfectants & Others); By End User (Equipment & Drug Usage) & By Geography – Forecast (2018-2023).’ The analyst of the report has worked on the report using statistical information related to hand sanitizer market, healthcare industry, and presented detailed information regarding how the market will grow in the upcoming years.

Infection Prevention and Control Market: Regional Analysis

According to the analyst of the report, the global infection prevention and control market is being led by North America. The revenue earned by this market in the North American region is set to rise with a CAGR of 4.3% throughout the forecast period. This is highly credited to the growing efforts made by the Centre for Disease Control and Prevention who have started numerous initiatives which stress the importance of preventing one’s self from pathogens in the hospital atmosphere. Another factor adding to this is the increase of end-user products in the general population owing to rising globalization and increase in disposable income.

View Full Table of Contents of Infection Prevention & Control Market:

Infection Prevention and Control Market: Growth Drivers

· Increase in Number of Surgical Procedures

According to Managaram, a member of the Hospital Infection Control Practices Advisory Committee, surgical infections are extremely prominent in the exposed areas during surgical procedures. These infections have a probability of manifesting within 30 days and can even lead to amputation.

· Aging Population

With first world countries housing a number of immigrants, the aging population has become common and governments are taking several initiatives to increase awareness amongst them regarding the prevention of infectious diseases.

Talk to one of our sales representative about the full report by providing your details in the link below:

Infection Prevention and Control Market: Competitive Landscape

The growth of this market depends on how well the key companies advertise their products and ensure that they reach the common citizens. These key market players include Abbott Laboratories, Alere Inc., Ansell Limited, AstraZeneca PLC, Bard Incorporated, Becton, Dickinson and Company, Belimed, Cantel Medical Corp, Covidien, Getinge Group, Hollister Incorporated, Johnson & Johnson, Kimberly Clark, Merck & Co., Pfizer Inc., Roche, Siemens Healthcare Diagnostics Inc., Supermax Corporation Berhad, Terumo Corporation, and the 3M Company.

Related Reports:

A. MEA Infection Prevention and Control Market in India

What can you expect from the report?
The Infection Prevention & Control Market is Prepared with the Main Agenda to Cover the following 20 points:
1. Infection prevention & Control Market Size by Product Categories & Application
2. Infection prevention & Control Market trends & Relevant Market Data
3. Manufacturer Landscape
4. Distributor Landscape
5. Pricing Analysis
6. Top 10 End-user Analysis
7. Product Benchmarking
8. Product Developments
9. Mergers & Acquisition Analysis
10. Patent Analysis
11. Infection prevention & Control Market Demand Analysis (Revenue & Volume)
12. Country-level Analysis
13. Competitor Analysis
14. Infection prevention & Control Market Shares Analysis
15. Value Chain Analysis
16. Supply Chain Analysis
17. Infection prevention & Control Market Strategic Analysis
18. Infection prevention & Control Market Current & Future Market Landscape Analysis
19. Opportunity Analysis
20. Infection prevention & Control Market Revenue and Volume Analysis

Frequently Asked Questions:

Q. Does IndustryARC provide customized reports and charge additionally for limited customization?

Response: Yes, we can customize the report by extracting data from our database of reports and annual subscription databases. We can provide the following free customization:

1. Increase the level of data in the application or end-user industry.

2. Increase the number of countries in geography chapter.

3. Find out market shares for other smaller companies or companies which are of interest to you.

4. Company profiles can be requested based on your interest.

5. Patent analysis, pricing, product analysis, product benchmarking, value and supply chain analysis can be requested for a country or end-use segment.

Any other custom requirements can be discussed with our team, drop an e-mail to to discuss more about our consulting services.

Media Contact:

Mr. Venkat Reddy

Sales Manager


Contact Sales: +1-614-588-8538 (Ext-101)

About IndustryARC: IndustryARC is a research and consulting firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life Sciences and Healthcare.


Go to website